Join us for an exclusive online session showcasing the latest developments in Embase, and a first look at Embase AI Chat. This webinar will cover major platform updates, including the integration of ClinicalTrials.gov data and enhanced indexing for drugs, devices, and adverse events. Attendees will gain practical insights into how new features support systematic reviews, adverse drug monitoring, and medical device safety — with a live demonstration of how Embase AI Chat can accelerate literature discovery and improve research efficiency.
Agenda
1. Introduction - The evolving role of Embase in biomedical research and evidence synthesis.
- Why you must use Embase for systematic literature review
2. Embase Content Expansion: ClinicalTrials.gov and SSRN Integration - Overview of the integration of ClinicalTrials.gov records into Embase.
- Upcoming 2025 enhancements: addition of eligibility criteria and study protocols to further support systematic reviews and trial design.
3. Innovations in Indexing, Data Coverage, and PubMed translation tool - Enhanced indexing of medical devices, drugs, and adverse events for regulatory compliance.
-Pubmed Translation tool
4. Embase AI Chat: Next-Generation Search and Discovery - Introduction to Embase AI chat and its capabilities for biomedical researchers.
- Use cases: supporting clinical decision-making, systematic reviews, and pharmacovigilance with AI-powered insights.
Customer Success Consultant, Life Sciences, Elsevier
Shimaa Heikal is a Customer Success Consultant for Life Sciences at Elsevier – based in Cairo, Egypt – where she supports a growing base of customers in the life sciences fields, including chemistry, biology, medicine, and pharmacy, using Reaxys...